Journal
PHARMACOLOGY & THERAPEUTICS
Volume 94, Issue 3, Pages 213-233Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/S0163-7258(02)00218-8
Keywords
catecholamine; norepinephrine; dopamine; seizure; epilepsy; knockout
Categories
Ask authors/readers for more resources
The catecholamines norepinephrine and dopamine are abundant in the CNS, and modulate neuronal excitability via G-protein-coupled receptor signaling. This review covers the history of research concerning the role of catecholamines in modulating seizure susceptibility in animal models of epilepsy. Traditionally, most work on this topic has been anatomical, pharmacological, or physiological in nature. However, the recent advances in transgenic and knockout mouse technology provide new tools to study catecholamines and their roles in seizure susceptibility. New results from genetically engineered mice with altered catecholamine signaling, as well as possibilities for future experiments, are discussed. (C) 2002 Elsevier Science Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available